Amantadine/ropiniroleLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1896卷 / 1期

关键词：

D O I：

10.1007/s40278-022-10823-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：32 / 32

相关论文

共 50 条

[1] Levodopa/RopiniroleLack of efficacy
Reactions Weekly, 2024, 2009 (1) : 336 - 336
[2] Amantadine/levodopa/selegilineOrofacial dyskinesia and lack of efficacy: case report
Reactions Weekly, 2021, 1868 (1) : 31 - 31
[3] Amantadine/edetic-acid/levodopaLack of efficacy: case report
Reactions Weekly, 2020, 1835 (1) : 20 - 20
[4] Amantadine/Lorazepam/QuetiapineVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2024, 2022 (1) : 22 - 22
[5] Amantadine/haloperidol/quetiapineWorsening of hallucination and lack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 56 - 56
[6] Amantadine/levodopa/levodopa/carbidopaDyskinesia and lack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 26 - 26
[7] Clonazepam/Pramipexole/RopiniroleLack of efficacy
Reactions Weekly, 2024, 2011 (1) : 128 - 128
[8] Amantadine withdrawalDelirium: case report
Reactions Weekly, 2017, 1663 (1) : 28 - 28
[9] Amantadine/memantineAgitation: case report
Reactions Weekly, 2021, 1840 (1) : 21 - 21
[10] Amantadine/selegilineInsomnia: case report
Reactions Weekly, 2019, 1761 (1) : 30 - 30

← 1 2 3 4 5 →